Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2008

Open Access 01-12-2008 | Research article

Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study

Authors: Klaus Kapelari, Christine Kirchlechner, Wolfgang Högler, Katharina Schweitzer, Irene Virgolini, Roy Moncayo

Published in: BMC Endocrine Disorders | Issue 1/2008

Login to get access

Abstract

Background

Age- and sex-specific reference intervals are an important prerequisite for interpreting thyroid hormone measurements in children. However, only few studies have reported age- and sex-specific pediatric reference values for TSHbasal (TSH), free T3 (fT3), and free T4 (fT4) so far. Reference intervals are known to be method- and population-dependent. The aim of our study was to establish reference intervals for serum TSH, fT3, and fT4 from birth to 18 years and to assess sex differences.

Methods

2,194 thyroid hormone tests obtained from a hospital-based pediatric population were included into our retrospective analysis. Individuals with diagnoses or medications likely to affect thyroid function were primarily excluded, as well as the diagnostic groups, if different from the purely healthy subgroup (n = 414). Age groups were ranging from 1 day to 1 month, 1 – 12 months, and 1 – 5, 6 – 10, 11 – 14, and 15 – 18 years, respectively. Levels of fT3, fT4 and TSH were measured on Advia® Centaur™ automated immunoassay system.

Results

The final sample size for reference data creation was 1,209 for TSH, 1,395 for fT3, and 1,229 for fT4. Median and 2.5/10/25/75/90/97.5 percentiles were calculated for each age group. Males had greater mean fT3 concentrations than females (p < 0.001). No sex-differences were found for TSH and fT4 between age-matched serum samples. Median concentrations of fT3, fT4 and TSH were greatest during the first month of life, followed by a continuous decline with age.

Conclusion

Our results corroborate those of previous studies showing that thyroid hormone levels change markedly during childhood, and that adult reference intervals are not universally applicable to children. Moreover, differences of our reference intervals compared to previous studies were observed, likely caused by different antibody characteristics of various analytical methods, different populations or undefined geographic covariates, e.g. iodine and selenium status.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dayan CM: Interpretation of thyroid function tests. Lancet. 2001, 357: 619-624. 10.1016/S0140-6736(00)04060-5.CrossRefPubMed Dayan CM: Interpretation of thyroid function tests. Lancet. 2001, 357: 619-624. 10.1016/S0140-6736(00)04060-5.CrossRefPubMed
2.
go back to reference Zurakowski D, Di Canzio J, Majzoub JA: Pediatric reference intervals for serum thyroxine, triiodothyronine, thyrotropin, and free thyroxine. Clin Chem. 1999, 45: 1087-1091.PubMed Zurakowski D, Di Canzio J, Majzoub JA: Pediatric reference intervals for serum thyroxine, triiodothyronine, thyrotropin, and free thyroxine. Clin Chem. 1999, 45: 1087-1091.PubMed
3.
go back to reference Elmlinger MW, Kuhnel W, Lambrecht HG, Ranke MB: Reference intervals from birth to adulthood for serum thyroxine (T4), triiodothyronine (T3), free T3, free T4, thyroxine binding globulin (TBG) and thyrotropin (TSH). Clin Chem Lab Med. 2001, 39: 973-979. 10.1515/CCLM.2001.158.CrossRefPubMed Elmlinger MW, Kuhnel W, Lambrecht HG, Ranke MB: Reference intervals from birth to adulthood for serum thyroxine (T4), triiodothyronine (T3), free T3, free T4, thyroxine binding globulin (TBG) and thyrotropin (TSH). Clin Chem Lab Med. 2001, 39: 973-979. 10.1515/CCLM.2001.158.CrossRefPubMed
4.
go back to reference Hubner U, Englisch C, Werkmann H, Butz H, Georgs T, Zabransky S, Herrmann W: Continuous age-dependent reference ranges for thyroid hormones in neonates, infants, children and adolescents established using the ADVIA Centaur Analyzer. Clin Chem Lab Med. 2002, 40: 1040-1047. 10.1515/CCLM.2002.182.CrossRefPubMed Hubner U, Englisch C, Werkmann H, Butz H, Georgs T, Zabransky S, Herrmann W: Continuous age-dependent reference ranges for thyroid hormones in neonates, infants, children and adolescents established using the ADVIA Centaur Analyzer. Clin Chem Lab Med. 2002, 40: 1040-1047. 10.1515/CCLM.2002.182.CrossRefPubMed
5.
go back to reference Soldin SJ, Morales A, Albalos F, Lenherr S, Rifai N: Pediatric reference ranges on the Abbott IMx for FSH, LH, prolactin, TSH, T4, T3, free T4, free T3, T-uptake, IgE, and ferritin. Clin Biochem. 1995, 28: 603-606. 10.1016/0009-9120(95)00038-5.CrossRefPubMed Soldin SJ, Morales A, Albalos F, Lenherr S, Rifai N: Pediatric reference ranges on the Abbott IMx for FSH, LH, prolactin, TSH, T4, T3, free T4, free T3, T-uptake, IgE, and ferritin. Clin Biochem. 1995, 28: 603-606. 10.1016/0009-9120(95)00038-5.CrossRefPubMed
6.
go back to reference Djemli A, Van Vliet G, Belgoudi J, Lambert M, Delvin EE: Reference intervals for free thyroxine, total triiodothyronine, thyrotropin and thyroglobulin for Quebec newborns, children and teenagers. Clin Biochem. 2004, 37: 328-330. 10.1016/j.clinbiochem.2003.12.006.CrossRefPubMed Djemli A, Van Vliet G, Belgoudi J, Lambert M, Delvin EE: Reference intervals for free thyroxine, total triiodothyronine, thyrotropin and thyroglobulin for Quebec newborns, children and teenagers. Clin Biochem. 2004, 37: 328-330. 10.1016/j.clinbiochem.2003.12.006.CrossRefPubMed
7.
go back to reference Wiedemann G, Jonetz-Mentzel L, Panse R: Establishment of reference ranges for thyrotropin, triiodothyronine, thyroxine and free thyroxine in neonates, infants, children and adolescents. Eur J Clin Chem Clin Biochem. 1993, 31: 277-278.PubMed Wiedemann G, Jonetz-Mentzel L, Panse R: Establishment of reference ranges for thyrotropin, triiodothyronine, thyroxine and free thyroxine in neonates, infants, children and adolescents. Eur J Clin Chem Clin Biochem. 1993, 31: 277-278.PubMed
8.
go back to reference Surks MI, Sievert R: Drugs and thyroid function. N Engl J Med. 1995, 333: 1688-1694. 10.1056/NEJM199512213332507.CrossRefPubMed Surks MI, Sievert R: Drugs and thyroid function. N Engl J Med. 1995, 333: 1688-1694. 10.1056/NEJM199512213332507.CrossRefPubMed
9.
go back to reference Vogeser M, Weigand M, Fraunberger P, Fischer H, Cremer P: Evaluation of the ADVIA Centaur TSH-3 assay. Clin Chem Lab Med. 2000, 38: 331-334. 10.1515/CCLM.2000.048.CrossRefPubMed Vogeser M, Weigand M, Fraunberger P, Fischer H, Cremer P: Evaluation of the ADVIA Centaur TSH-3 assay. Clin Chem Lab Med. 2000, 38: 331-334. 10.1515/CCLM.2000.048.CrossRefPubMed
10.
go back to reference Rawlins ML, Roberts WL: Performance characteristics of six third-generation assays for thyroid-stimulating hormone. Clin Chem. 2004, 50: 2338-2344. 10.1373/clinchem.2004.039156.CrossRefPubMed Rawlins ML, Roberts WL: Performance characteristics of six third-generation assays for thyroid-stimulating hormone. Clin Chem. 2004, 50: 2338-2344. 10.1373/clinchem.2004.039156.CrossRefPubMed
11.
go back to reference Moncayo R, Moncayo H, Virgolini I: Reference values for thyrotropin. Thyroid. 2005, 15: 1204-1205.PubMed Moncayo R, Moncayo H, Virgolini I: Reference values for thyrotropin. Thyroid. 2005, 15: 1204-1205.PubMed
12.
go back to reference Moncayo H, Dapunt O, Moncayo R: Diagnostic accuracy of basal TSH determinations based on the intravenous TRH stimulation test: an evaluation of 2570 tests and comparison with the literature. BMC Endocr Disord. 2007, 7: 5-10.1186/1472-6823-7-5.CrossRefPubMedPubMedCentral Moncayo H, Dapunt O, Moncayo R: Diagnostic accuracy of basal TSH determinations based on the intravenous TRH stimulation test: an evaluation of 2570 tests and comparison with the literature. BMC Endocr Disord. 2007, 7: 5-10.1186/1472-6823-7-5.CrossRefPubMedPubMedCentral
13.
go back to reference Surks MI, Goswami G, Daniels GH: The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab. 2005, 90: 5489-5496. 10.1210/jc.2005-0170.CrossRefPubMed Surks MI, Goswami G, Daniels GH: The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab. 2005, 90: 5489-5496. 10.1210/jc.2005-0170.CrossRefPubMed
14.
go back to reference Draper NR: Applied regression analysis bibliography update 1994–97. Communications in Statistics-Theory and Methods. 1998, 27: 2581-2623. 10.1080/03610929808832244.CrossRef Draper NR: Applied regression analysis bibliography update 1994–97. Communications in Statistics-Theory and Methods. 1998, 27: 2581-2623. 10.1080/03610929808832244.CrossRef
15.
go back to reference Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, Segal RL: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation of treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002, 8: 457-467.PubMed Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, Segal RL: American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation of treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002, 8: 457-467.PubMed
17.
go back to reference Zophel K, Wunderlich G, Gruning T, Koch R, Doge H, Kotzerke J: [Where does subclinical hypothyroidism start? Implications for the definition of the upper reference limit for thyroid stimulating hormone]. Nuklearmedizin. 2005, 44: 56-61.PubMed Zophel K, Wunderlich G, Gruning T, Koch R, Doge H, Kotzerke J: [Where does subclinical hypothyroidism start? Implications for the definition of the upper reference limit for thyroid stimulating hormone]. Nuklearmedizin. 2005, 44: 56-61.PubMed
18.
go back to reference Zophel K, Wunderlich G, Kotzerke J: Should we really determine a reference population for the definition of thyroid-stimulating hormone reference interval?. Clin Chem. 2006, 52: 329-330. 10.1373/clinchem.2005.060111.CrossRefPubMed Zophel K, Wunderlich G, Kotzerke J: Should we really determine a reference population for the definition of thyroid-stimulating hormone reference interval?. Clin Chem. 2006, 52: 329-330. 10.1373/clinchem.2005.060111.CrossRefPubMed
19.
go back to reference Kratzsch J, Fiedler GM, Leichtle A, Brugel M, Buchbinder S, Otto L, Sabri O, Matthes G, Thiery J: New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem. 2005, 51: 1480-1486. 10.1373/clinchem.2004.047399.CrossRefPubMed Kratzsch J, Fiedler GM, Leichtle A, Brugel M, Buchbinder S, Otto L, Sabri O, Matthes G, Thiery J: New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem. 2005, 51: 1480-1486. 10.1373/clinchem.2004.047399.CrossRefPubMed
20.
go back to reference d'Herbomez M, Forzy G, Gasser F, Massart C, Beaudonnet A, Sapin R: Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations. Clin Chem Lab Med. 2003, 41: 942-947. 10.1515/CCLM.2003.143.CrossRefPubMed d'Herbomez M, Forzy G, Gasser F, Massart C, Beaudonnet A, Sapin R: Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations. Clin Chem Lab Med. 2003, 41: 942-947. 10.1515/CCLM.2003.143.CrossRefPubMed
21.
go back to reference Demers LM, Spencer CA: Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol (Oxf). 2003, 58: 138-140. 10.1046/j.1365-2265.2003.01681.x.CrossRef Demers LM, Spencer CA: Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol (Oxf). 2003, 58: 138-140. 10.1046/j.1365-2265.2003.01681.x.CrossRef
22.
go back to reference Soukhova N, Soldin OP, Soldin SJ: Isotope dilution tandem mass spectrometric method for T4/T3. Clin Chim Acta. 2004, 343: 185-190. 10.1016/j.cccn.2004.01.007.CrossRefPubMedPubMedCentral Soukhova N, Soldin OP, Soldin SJ: Isotope dilution tandem mass spectrometric method for T4/T3. Clin Chim Acta. 2004, 343: 185-190. 10.1016/j.cccn.2004.01.007.CrossRefPubMedPubMedCentral
23.
go back to reference Gu J, Soldin OP, Soldin SJ: Simultaneous quantification of free triiodothyronine and free thyroxine by isotope dilution tandem mass spectrometry. Clin Biochem. 2007, 40: 1386-1391. 10.1016/j.clinbiochem.2007.08.007.CrossRefPubMed Gu J, Soldin OP, Soldin SJ: Simultaneous quantification of free triiodothyronine and free thyroxine by isotope dilution tandem mass spectrometry. Clin Biochem. 2007, 40: 1386-1391. 10.1016/j.clinbiochem.2007.08.007.CrossRefPubMed
24.
go back to reference Soldin SJ, Soukhova N, Janicic N, Jonklaas J, Soldin OP: The measurement of free thyroxine by isotope dilution tandem mass spectrometry. Clin Chim Acta. 2005, 358: 113-118. 10.1016/j.cccn.2005.02.010.CrossRefPubMedPubMedCentral Soldin SJ, Soukhova N, Janicic N, Jonklaas J, Soldin OP: The measurement of free thyroxine by isotope dilution tandem mass spectrometry. Clin Chim Acta. 2005, 358: 113-118. 10.1016/j.cccn.2005.02.010.CrossRefPubMedPubMedCentral
25.
go back to reference Despres N, Grant AM: Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem. 1998, 44: 440-454.PubMed Despres N, Grant AM: Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem. 1998, 44: 440-454.PubMed
26.
go back to reference Landau-Levine M, Way BA, Clutter WE, Scott MG, Gronowski AM: Antibody interference with the Abbott AxSym immunoassay for thyroid-stimulating hormone. Clin Chim Acta. 1999, 281: 177-180. 10.1016/S0009-8981(98)00213-7.CrossRefPubMed Landau-Levine M, Way BA, Clutter WE, Scott MG, Gronowski AM: Antibody interference with the Abbott AxSym immunoassay for thyroid-stimulating hormone. Clin Chim Acta. 1999, 281: 177-180. 10.1016/S0009-8981(98)00213-7.CrossRefPubMed
27.
go back to reference Martel J, Despres N, Ahnadi CE, Lachance JF, Monticello JE, Fink G, Ardemagni A, Banfi G, Tovey J, Dykes P: Comparative multicentre study of a panel of thyroid tests using different automated immunoassay platforms and specimens at high risk of antibody interference. Clin Chem Lab Med. 2000, 38: 785-793. 10.1515/CCLM.2000.112.CrossRefPubMed Martel J, Despres N, Ahnadi CE, Lachance JF, Monticello JE, Fink G, Ardemagni A, Banfi G, Tovey J, Dykes P: Comparative multicentre study of a panel of thyroid tests using different automated immunoassay platforms and specimens at high risk of antibody interference. Clin Chem Lab Med. 2000, 38: 785-793. 10.1515/CCLM.2000.112.CrossRefPubMed
28.
go back to reference Kricka LJ: Interferences in immunoassay–still a threat. Clin Chem. 2000, 46: 1037-1038.PubMed Kricka LJ: Interferences in immunoassay–still a threat. Clin Chem. 2000, 46: 1037-1038.PubMed
29.
go back to reference Ekins R: Validity of analog free thyroxin immunoassays. Clin Chem. 1987, 33: 2137-2144.PubMed Ekins R: Validity of analog free thyroxin immunoassays. Clin Chem. 1987, 33: 2137-2144.PubMed
30.
go back to reference Kahric-Janicic N, Soldin SJ, Soldin OP, West T, Gu J, Jonklaas J: Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid. 2007, 17: 303-311. 10.1089/thy.2006.0303.CrossRefPubMedPubMedCentral Kahric-Janicic N, Soldin SJ, Soldin OP, West T, Gu J, Jonklaas J: Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid. 2007, 17: 303-311. 10.1089/thy.2006.0303.CrossRefPubMedPubMedCentral
31.
go back to reference Waskiewicz D, Burkhardt A, Emancipator K: Performance characteristics of 6 third-generation assays for thyroid-stimulating hormone. Clin Chem. 2005, 51: 1904-1905. 10.1373/clinchem.2005.055632.CrossRefPubMed Waskiewicz D, Burkhardt A, Emancipator K: Performance characteristics of 6 third-generation assays for thyroid-stimulating hormone. Clin Chem. 2005, 51: 1904-1905. 10.1373/clinchem.2005.055632.CrossRefPubMed
32.
go back to reference Singh RJ, Eisenhofer G: High-throughput, automated, and accurate biochemical screening for pheochromocytoma: are we there yet?. Clin Chem. 2007, 53: 1565-1567. 10.1373/clinchem.2007.089128.CrossRefPubMed Singh RJ, Eisenhofer G: High-throughput, automated, and accurate biochemical screening for pheochromocytoma: are we there yet?. Clin Chem. 2007, 53: 1565-1567. 10.1373/clinchem.2007.089128.CrossRefPubMed
33.
go back to reference Kouri T, Kairisto V, Virtanen A, Uusipaikka E, Rajamaki A, Finneman H, Juva K, Koivula T, Nanto V: Reference intervals developed from data for hospitalized patients: computerized method based on combination of laboratory and diagnostic data. Clin Chem. 1994, 40: 2209-2215.PubMed Kouri T, Kairisto V, Virtanen A, Uusipaikka E, Rajamaki A, Finneman H, Juva K, Koivula T, Nanto V: Reference intervals developed from data for hospitalized patients: computerized method based on combination of laboratory and diagnostic data. Clin Chem. 1994, 40: 2209-2215.PubMed
34.
go back to reference Harwood SJ, Cole GW: Reference values based on hospital admission laboratory data. JAMA. 1978, 240: 270-274. 10.1001/jama.240.3.270.CrossRefPubMed Harwood SJ, Cole GW: Reference values based on hospital admission laboratory data. JAMA. 1978, 240: 270-274. 10.1001/jama.240.3.270.CrossRefPubMed
35.
go back to reference Diez JJ, Iglesias P, Burman KD: Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 2005, 90: 4124-4127. 10.1210/jc.2005-0375.CrossRefPubMed Diez JJ, Iglesias P, Burman KD: Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 2005, 90: 4124-4127. 10.1210/jc.2005-0375.CrossRefPubMed
36.
go back to reference Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, Smith SA, Daniels GH: American thyroid association guidelines for detection of thyroid dysfunction. Archives of Internal Medicine. 2000, 160: 1573-1575. 10.1001/archinte.160.11.1573.CrossRefPubMed Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, Smith SA, Daniels GH: American thyroid association guidelines for detection of thyroid dysfunction. Archives of Internal Medicine. 2000, 160: 1573-1575. 10.1001/archinte.160.11.1573.CrossRefPubMed
37.
go back to reference Cooper DS: Clinical practice. Subclinical hypothyroidism. N Engl J Med. 2001, 345: 260-265. 10.1056/NEJM200107263450406.CrossRefPubMed Cooper DS: Clinical practice. Subclinical hypothyroidism. N Engl J Med. 2001, 345: 260-265. 10.1056/NEJM200107263450406.CrossRefPubMed
38.
go back to reference Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P, Braverman LE: Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab. 2002, 87: 3221-3226. 10.1210/jc.87.7.3221.CrossRefPubMed Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P, Braverman LE: Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab. 2002, 87: 3221-3226. 10.1210/jc.87.7.3221.CrossRefPubMed
39.
go back to reference Stephens PA: The Endocrine Society: current issues in thyroid disease management. Endocr News. 2004, 29: 23-26. Stephens PA: The Endocrine Society: current issues in thyroid disease management. Endocr News. 2004, 29: 23-26.
40.
go back to reference Dayan CM, Saravanan P, Bayly G: Whose normal thyroid function is better–yours or mine?. Lancet. 2002, 360: 353-10.1016/S0140-6736(02)09602-2.CrossRefPubMed Dayan CM, Saravanan P, Bayly G: Whose normal thyroid function is better–yours or mine?. Lancet. 2002, 360: 353-10.1016/S0140-6736(02)09602-2.CrossRefPubMed
41.
go back to reference Fatourechi V, Klee GG, Grebe SK, Bahn RS, Brennan MD, Hay ID, McIver B, Morris JC: Effects of reducing the upper limit of normal TSH values. JAMA. 2003, 290: 3195-3196. 10.1001/jama.290.24.3195-b.CrossRefPubMed Fatourechi V, Klee GG, Grebe SK, Bahn RS, Brennan MD, Hay ID, McIver B, Morris JC: Effects of reducing the upper limit of normal TSH values. JAMA. 2003, 290: 3195-3196. 10.1001/jama.290.24.3195-b.CrossRefPubMed
Metadata
Title
Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study
Authors
Klaus Kapelari
Christine Kirchlechner
Wolfgang Högler
Katharina Schweitzer
Irene Virgolini
Roy Moncayo
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2008
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-8-15

Other articles of this Issue 1/2008

BMC Endocrine Disorders 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine